Brief: Bioventus Q4 Adjusted EPS USD 0.15
11/03/2025 11:30
Mar 11 (Reuters) - Bioventus Q4 adjusted EBITDA USD 28.3 million. Q4 sales USD 153.6 million
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks